- Home
- Equipment
- usa pennsylvania
- clinical trial
Show results for
Refine by
Clinical Trial Equipment Supplied In Usa Pennsylvania
21 equipment items found
by:Traws Pharma based inNewtown, PENNSYLVANIA (USA)
Rigosertib is a small molecule that inhibits multiple cellular signaling pathways driving cancer cell growth while having little effect on normal cells. In contrast to many kinase inhibitors, rigosertib does not interact at the ATP binding site, but acts via allosteric inhibition. Rigosertib has the potential to affect three critical pathways for cancer cell proliferation and survival: the ...
Manufactured by:Galera Therapeutics, Inc. based inMalvern, PENNSYLVANIA (USA)
Avasopasem manganese (GC4419) is an investigational selective dismutase mimetic drug in development as a radioprotector in combination with radiation therapy (RT), with the goal to reduce side effects from radiation therapy. In preclinical studies, our selective dismutase mimetics significantly reduced immediate and long-term radiation damage to normal tissue in a variety of organs. Avasopasem ...
Manufactured by:Suvoda based inConshohocken, PENNSYLVANIA (USA)
Full visibility and automated control. Extend your clinical trial command and control center with Suvoda’s integrated ...
Manufactured by:Suvoda based inConshohocken, PENNSYLVANIA (USA)
Overcome the traditional challenges of electronic outcomes data collection and submission for complex clinical ...
by:Forest Devices based inPittsburgh, PENNSYLVANIA (USA)
Forest Devices has developed a disruptive technology: the first objective, electronically-determined test for stroke for use by EMS. shown an increase in diagnostic accuracy of 92% in pilot clinical trials of nearly 300 people expected to reduce — and possibly eliminate in some cases — disabilities, rehabilitation costs and even death from stroke ...
Manufactured by:Suvoda based inConshohocken, PENNSYLVANIA (USA)
Our advanced patient randomization and trial supply management system. Your clinical trial command and control ...
Manufactured by:Adaptimmune LLC based inPhiladelphia, PENNSYLVANIA (USA)
Our ADP-A2AFP SPEAR T-cell product targets alpha-fetoprotein (AFP) is being investigated in an ongoing Phase 1 clinical trial for the treatment of patients with hepatocellular carcinoma (liver ...
Manufactured by:INOVIO Pharmaceuticals based inPlymouth Meeting, PENNSYLVANIA (USA)
INOVIO has employed its CELLECTRA®2000 smart delivery device for over a decade in more than 40 oncology and infectious disease clinical trials, including those for COVID-19 disease. For intramuscular delivery, INOVIO uses its CELLECTRA 5PSP in its Phase 3 clinical trial for VGX-3100. INOVIO is developing its next-generation ...
Manufactured by:Lipella Pharmaceuticals Inc. based inPittsburgh, PENNSYLVANIA (USA)
Hemorrhagic Cystitis, also called Radiation Cystitis when occurring after pelvic radiation. Lipella is currently conducting a phase-2a, dose-escalation clinical trial evaluating LP-10 (liposomal tacrolimus) for the treatment of hemorrhagic cystitis. Lipella has received US-FDA Orphan Designation for this developmental product. Radiation used to treat prostate, ...
Manufactured by:Cabaletta Bio, Inc. based inPhiladelphia, PENNSYLVANIA (USA)
DSG3/1-CAART is designed to selectively target and kill the B cells that express the pathogenic autoantibodies while preserving the healthy B cells critical to immune function. We anticipate that much of what we learn from our DSG3-CAART program, including clinical trial design in the DesCAARTesTM trial, will inform and potentially accelerate the ...
Manufactured by:LAVA Therapeutics N.V. based inUtrecht, NETHERLANDS
LAVA-051 uniquely activates both Vγ9Vδ2 T cells as well as invariant natural killer T cells, which represent another conserved immune effector cell population, in a target dependent manner. We plan to begin a Phase I/IIa clinical trial in patients with relapsed and/or refractory multiple myeloma and CLL in the first half of ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro has spent 20 years specializing in neuroscience imaging solutions for preclinical, early phase and late phase clinical studies. Our capabilities span from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials. We have expertise in coordinating worldwide ...
Manufactured by:Novartis International AG based inBasel, SWITZERLAND
Our investigational gene therapy, GT005, is designed to restore balance to a part of our immune system called the complement ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Our DecisionDx-CMSeq is a 3-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to cutaneous melanoma in melanoma tumor tissue. The test includes hotspot mutations in the genes BRAF, NRAS and ...
Manufactured by:Xodus Medical Inc. based inNew Kensington, PENNSYLVANIA (USA)
Safety Maximized: Increase patient safety with Pink Lat Packs; featuring breathable, moisture-wicking materials that immerse and envelope areas prone to pressure ...
Manufactured by:Amicus Therapeutics, Inc. based inPhiladelphia, PENNSYLVANIA (USA)
This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory ...
Manufactured by:Piramal Critical Care (PCC) based inBethlehem, PENNSYLVANIA (USA)
These highlights do not include all the information needed to use LINEZOLID INJECTION safely and effectively. See full prescribing information for LINEZOLID ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Uveal melanoma, commonly known as ocular or choroidal melanoma, is a rare cancer of the eye with approximately 2,000 patients diagnosed annually in the U.S. At the time of initial diagnosis, approximately 97% of patients are free of metastasis. However, within five years, approximately 30% of patients will develop metastasis – rising to nearly 50% in the following ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
Cell Therapy Systems—a proven choice for clinical cell therapy manufacturing. As you move from basic cell therapy research to the clinic, high-quality GMP-grade cell therapy ancillary materials and proper documentation are essential to getting it right the first time. Cell Therapy Systems (CTS) products provide a proven choice for clinical stem cell therapy and immunotherapy research and ...